Ucommune International Ltd. UK
2.10
0.00
0.00%
as of 25 Sep
- Market cap
- $1.4M
- P/E
- 0.0×
Follow UK
| Jun '25 | Jun '24 | Jun '23 | Dec '22 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | (196.14%) | (196.59%) |
+8 more TTM periods Free account |
|
| 0.00% | 0.00% | (88.52%) | (85.41%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 1,129.41% | (6,781.45%) | |
Average Days of Receivables |
0.00 | 0.00 | 36.57 | 64.80 | |
Free Cash Flow per Share |
— | 0.00 | (100.32) | (69.05) | |
Free Cash Flow |
— | (41.69) | (44.53) | (29.49) | |
Capital Expenditures |
— | (19.74) | (19.53) | — | |
Piotroski F-Score |
— | — | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
0.00% | (140.66%) | (79.33%) | (41.28%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 9.14 | 6.86 | |
Accounts Payable Turnover |
0.00 | 0.00 | 5.88 | 5.33 | |
Inventory Turnover |
— | — | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 59.90 | 73.18 | |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | |
Tax Rate |
— | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | 21.70% | 26.41% | |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | |
Operating CF/Net income |
— | 0.00 | 0.09 | 0.10 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | 0.00 | 0.00 | — | |
Revenue per Share |
— | — | 409.76 | 430.78 | |
Operating CF per Share |
— | 0.00 | (56.33) | (69.05) | |
Capex per Share |
— | 0.00 | (43.99) | 0.00 | |
Capex to Sales |
— | 0.00 | 0.11 | 0.00 | |
Net Profit Margin |
— | — | (158.43%) | (168.11%) |
Columns are period end dates